MSN Laboratories Private Limited — Atorvastatin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Atorvastatin · $83.7M export value · DGFT Verified
MSN Laboratories Private Limited is the #4 Indian exporter of Atorvastatin with $83.7M in export value and 3,224 verified shipments. MSN Laboratories Private Limited holds a 7.7% market share in Atorvastatin exports across 20 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.
MSN Laboratories Private Limited — Atorvastatin Export Profile: Buyers & Destinations
Where Does MSN Laboratories Private Limited Export Atorvastatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $38.9M | 1,485 | 49.7% |
| UNITED KINGDOM | $15.6M | 827 | 19.9% |
| CHILE | $12.8M | 502 | 16.4% |
| GERMANY | $3.0M | 164 | 3.8% |
| FINLAND | $2.4M | 115 | 3.0% |
| UNITED STATES OF AMERICA | $1.5M | 35 | 1.9% |
| MALTA | $1.3M | 172 | 1.6% |
| NETHERLANDS | $1.1M | 75 | 1.3% |
| JAMAICA | $969.8K | 66 | 1.2% |
| SPAIN | $267.1K | 22 | 0.3% |
MSN Laboratories Private Limited exports Atorvastatin to 24 countries. The largest destination is UNITED STATES accounting for 49.7% of MSN Laboratories Private Limited's Atorvastatin shipments, followed by UNITED KINGDOM (19.9%) and CHILE (16.4%). These destinations reflect MSN Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Atorvastatin from MSN Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | UNITED STATES | $30.7M | 1,362 |
| NOVADOZ PHARMACEUTICALS LLC | UNITED STATES | $17.0M | 635 |
| MSN LABORATORIES EUROPE LIMITED | UNITED KINGDOM | $6.2M | 227 |
| MSN LABORATORIES EUROPE LIMITED., | UNITED KINGDOM | $4.6M | 233 |
| MSN LABS CHILE S.P.A | CHILE | $3.7M | 176 |
| MSN LABS CHILE SPA | CHILE | $3.3M | 104 |
| TO THE ORDER | UNITED STATES | $2.2M | 103 |
| MSN LABORATORIES EUROPE LIMITED. | UNITED KINGDOM | $1.5M | 33 |
| ORION CORPORATION | FINLAND | $1.0M | 46 |
| VIVANTA GENERICS | NETHERLANDS | $808.2K | 53 |
MSN Laboratories Private Limited supplies Atorvastatin to 77 buyers globally. The largest buyer is TO THE ORDER OF (UNITED STATES), followed by NOVADOZ PHARMACEUTICALS LLC (UNITED STATES) and MSN LABORATORIES EUROPE LIMITED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Atorvastatin Export Value and How Much Does MSN Laboratories Private Limited Contribute?
India exported $313.7M worth of Atorvastatin through 15,000 shipments from 477 suppliers to 145 countries, serving 1,291 buyers globally. MSN Laboratories Private Limited contributes $83.7M to this total, accounting for 7.7% of India's Atorvastatin exports. MSN Laboratories Private Limited ships Atorvastatin to 24 countries through 77 buyers.
What Is the Average Shipment Value for MSN Laboratories Private Limited's Atorvastatin Exports?
MSN Laboratories Private Limited's average Atorvastatin shipment value is $26.0K per consignment, based on 3,224 shipments totaling $83.7M. The largest destination is UNITED STATES (49.7% of MSN Laboratories Private Limited's Atorvastatin exports).
How Does MSN Laboratories Private Limited Compare to Other Indian Atorvastatin Exporters?
MSN Laboratories Private Limited ranks #4 among 477 Indian Atorvastatin exporters with a 7.7% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($83.7M), AUROBINDO PHARMA LTD ($33.2M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($32.8M). MSN Laboratories Private Limited processed 3,224 shipments to 20 destination countries.
What Atorvastatin Formulations Does MSN Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ATORVASTATIN TAB 40 MG X 28'S MSN UK | $3.4M | 145 |
| ATORVASTATIN TABLETS 40MG 1000'S NOVADOZ | $2.6M | 73 |
| MSN PHARMA ATORVASTATIN TABLETS 40MG 100 | $2.6M | 175 |
| ATORVASTATIN TAB 20 MG X 28'S MSN UKNOS | $1.9M | 51 |
| ATORVASTATIN TAB 80 MG X 28'S MSN UK | $1.8M | 91 |
| (MSN PHARMACEUTICALS) ATORVASTATINA 20 ( | $1.7M | 43 |
| ATORVASTATIN TABLETS 40MG 500'S | $1.5M | 35 |
| ATORVASTATIN TAB 20 MG X 28'S MSN UK | $1.5M | 52 |
| ATORVASTATIN TABLETS 40MG 1000'S NOVADOZNOS | $1.1M | 41 |
| ATORVASTATIN TABLETS 20MG 1000'S NOVADOZ | $1.1M | 31 |
MSN Laboratories Private Limited exports 837 distinct Atorvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ATORVASTATIN TAB 40 MG X 28'S MSN UK with 145 shipments worth $3.4M.
Regulatory Requirements: Exporting Atorvastatin to Key Markets
What MSN Laboratories Private Limited must comply with to export Atorvastatin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does MSN Laboratories Private Limited Compare to Nearest Atorvastatin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | MSN LABORATORIES PRIVATE LIMITED ★ | $83.7M | 3,224 | 20 | $26.0K |
| 7 | AUROBINDO PHARMA LTD | $33.2M | 879 | 11 | $37.7K |
| 8 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $32.8M | 1,299 | 18 | $25.3K |
MSN Laboratories Private Limited ranks #4 among 477 Indian Atorvastatin exporters. Average shipment value of $26.0K compared to the market average of $657.7K. The closest competitors by value are AUROBINDO PHARMA LTD and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
Which Indian Ports Ship Atorvastatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| HYDERABAD ICD | 2,042 | 13.6% |
| HYDERABAD ICD (INSNF6) | 1,131 | 7.5% |
| NHAVA SHEVA SEA (INNSA1) | 842 | 5.6% |
| SAHAR AIR | 839 | 5.6% |
| JNPT/ NHAVA SHEVA SEA | 779 | 5.2% |
| DELHI AIR | 613 | 4.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 581 | 3.9% |
| HYDERABAD AIR | 554 | 3.7% |
What Other Cardiovascular Products Does MSN Laboratories Private Limited Export?
MSN Laboratories Private Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Atorvastatin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.
MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.
MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.
About MSN Laboratories Private Limited
MSN Laboratories Private Limited exports 32 products worth $252.1M. Beyond Atorvastatin, top products include Rosuvastatin, Ras, Oseltamivir, Calcium, Losartan. View the complete MSN Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Atorvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 3,589 individual customs records matching MSN Laboratories Private Limited exporting Atorvastatin, covering 837 formulations to 24 countries via 77 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 145+ countries, 1,291+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Atorvastatin Export Data from MSN Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for MSN Laboratories Private Limited's Atorvastatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MSN Laboratories Private Limited
Full Company Profile →
32 products · $252.1M total trade · 15 categories
Atorvastatin Stats
Company Overview
Top Products by MSN Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for MSN Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Atorvastatin. For current shipment-level data, contact TransData Nexus.